Ribosomal protein L12 pseudogene 23 (RPL12P23)

Ribosomal protein L12 pseudogene 23 (RPL12P23) is a processed pseudogene found in the human genome, related to the ribosomal protein L12 gene family. Processed pseudogenes such as RPL12P23 do not encode functional proteins and are not considered therapeutic targets in drug discovery or clinical practice. While some pseudogenes can contribute to gene regulation or serve as disease-associated noncoding RNAs, there is currently no evidence that RPL12P23 plays an active role in biological functions, disease mechanisms, or drug response[8][5]. RPL12P23 should be distinguished from the functional RPL12 gene, which encodes the ribosomal protein L12 — a structural ribosomal component involved in protein synthesis[1][4][6]. RPL12P23’s nomenclature, sequence, and genomic location are derived from its parental gene, but it is not a protein-coding entity and is not part of known molecular families commonly sought in therapeutic targeting (e.g., receptor, enzyme, transporter)[8][5]. If you intended to refer to the functional ribosomal protein L12 (RPL12), further clarification is needed, as this summary pertains strictly to the pseudogene (RPL12P23), which lacks known clinical or therapeutic relevance.

Other names

RPL12_7_777RPL12P23